Healthcare Industry News:  TYKERB 

Biopharmaceuticals Oncology

 News Release - March 13, 2007

GlaxoSmithKline Announces Expansion of Patient Assistance Program to Include TYKERB(R)

PHILADELPHIA, March 13 (HSMN NewsFeed) -- GlaxoSmithKline (NYSE: GSK ) has confirmed that its new treatment TYKERB® (lapatinib) will be available through Commitment to Access, the company's program that provides low income patients with access to GSK products used in an outpatient setting in the United States.

As part of Commitment to Access, patients who have been prescribed TYKERB and have no insurance coverage may be eligible to receive TYKERB free of charge if they live in one of the 50 states or the District of Columbia and their income is at or below 500 percent of the federal poverty level (For example, $68,450 for a household of two. Income eligibility is adjusted for household size). (1)

For patients enrolled in a Medicare Part D plan, eligibility also requires documentation of $600 in expenditures on prescription medicines in the current calendar year. Patients who are eligible for Medicare and who have incomes below 135 percent of the federal poverty level may not be eligible for GSK's patient assistance programs if they qualify for full assistance under Medicare.

More information regarding Commitment to Access is available at and by calling 1-866-475-3678.

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. For more than twenty years, GlaxoSmithKline and its predecessor companies have provided assistance to those who need help in getting their medicines. Last year, GSK provided nearly 402,000 patients more than $370 million in free medicines through its patient assistance programs that benefit low income patients of all ages. For company information, visit GlaxoSmithKline at

US Media Inquiries: Sarah Alspach +1 919 483 2839
Mary Anne Rhyne +1 919 483 2839

(1) Alaska: $85,600/household of two; Hawaii: $78,560/household of two. United States Department of Health and Human Services, 2007 HHS Poverty Guidelines. Available online at

Source: GlaxoSmithKline

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.